株探米国株
英語
エドガーで原本を確認する
false 0001173489 0001173489 2025-02-10 2025-02-10
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): February 10, 2025
 

 
CEVA, INC.
(Exact Name of Registrant as Specified in Charter)
 

 
Delaware
 
000-49842
 
77-0556376
(State or Other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
15245 Shady Grove Road, Suite 400, Rockville, MD 20850
(Address of Principal Executive Offices, and Zip Code)
 
(240) 308-8328
Registrant’s Telephone Number, Including Area Code
 
Not applicable 
(Former Name or Former Address, if Changed Since Last Report)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which
registered
Common Stock, $0.001 par value
 
CEVA
 
The Nasdaq Global Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


 






 
ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
 
2025 Executive Bonus Plan for Chief Executive Officer, Chief Financial Officer and Chief Operating Officer
 
On February 10, 2025, the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Ceva, Inc. (the “Corporation”) approved a 2025 Executive Bonus Plan (the “2025 Executive Plan”), effective as of January 1, 2025, for Amir Panush, the Corporation’s Chief Executive Officer, Yaniv Arieli, the Corporation’s Chief Financial Officer, and Michael Boukaya, the Corporation’s Chief Operating Officer.
 
The Committee believes that the 2025 Executive Plan is an important part of maintaining the overall competitiveness of the Corporation’s executive compensation program and serves as an effective device to motivate its executive officers to achieve the financial and strategic goals and objectives reflected in the Corporation’s annual operating plan, which are designed to further the creation of long-term stockholder value.
 
Parameters of the 2025 Executive Plan are as follows:
 
Weighting
Financial Target
Threshold
for Receipt
of Bonus
Linear Calculation Above
90%
of Target
Linear Calculation above 100% of
Target
40% to Target
Specified 2025 revenue target approved by the Board (the “2025 Revenue Target”)
90% of 2025 Revenue Target
If the Corporation achieves between 90% and 100% of the 2025 Revenue Target, that percentage of the bonus amount, subject to 40% weighting, would be payable
For the 2025 Revenue Target, if the actual result exceeds 100% of the target, every 1% increase above the target, up to 110%, would result in an increase of 10% for Mr. Panush and an increase of 5% for each of Messrs. Arieli and Boukaya, subject to 40% weighting
40% to Target
Specified 2025 non-GAAP operating profit approved by the Board (the “2025 Operating Profit Target”)
90% of 2025 Operating Profit Target
If the Corporation achieves between 90% and 100% of the 2025 Operating Profit Target, that percentage of the bonus amount, subject to 40% weighting, would be payable
For the 2025 Operating Profit Target, if the actual result exceeds 100% of the target, every 1% increase above the target, up to 110%, would result in an increase of 10% for Mr. Panush and an increase of 5% for each of Messrs. Arieli and Boukaya, subject to 40% weighting
 






 
In addition, 5% weighting will be applied for achieving certain internal business metrics, and 15% weighting will be applied at the discretion of the Committee (the “2025 Additional Targets”), the achievement of which will be determined by the Committee in its sole discretion.
 
Under the 2025 Executive Plan, the target annual cash incentive award opportunities for each of Messrs. Panush, Arieli and Boukaya are established as a percentage of each such executive officer's base salary for 2025. The target and maximum award opportunities for Messrs. Panush, Arieli and Boukaya for 2025 are as follows:
 
Named Executive Officer
 
Target Award
(as a percentage of base salary)
   
Maximum Award
(as a percentage of base salary)
 
Amir Panush
    100 %     200 %
Yaniv Arieli
    70 %     98 %
Michael Boukaya
    70 %     98 %
 
Payment of bonuses (if any) will be made in 2026. Bonuses will be paid in cash in a single lump sum, subject to payroll taxes and tax holdings.
 
Due to their strategic significance, the Corporation believes that the disclosure of the 2025 Revenue Target, 2025 Operating Profit Target and 2025 Additional Targets under the 2025 Executive Plan and, as applicable, the 2025 Incentive Bonus Plan discussed below, would cause future competitive harm to the Corporation and therefore are not disclosed.
 
The above is a description of the 2025 Executive Plan provided pursuant to Paragraph 10(iii) to Item 601 of Regulation S-K, which requires a written description of a compensatory plan when there is no formal document containing the compensation information.
 
2025 Incentive Bonus Plan for Chief Commercial Officer
 
On February 10, 2025, the Committee approved the 2025 Incentive Plan (the “Toquet 2025 Plan”) for Gweltaz Toquet, the Corporation’s Chief Commercial Officer, effective as of January 1, 2025.
 
In accordance with the Toquet 2025 Plan, the first portion of his bonus is based on a formula using the 2025 Revenue Target multiplied by a specified commission rate. With regard to this component, a commission multiplier of 1.0 is applied to the commission rate based on 0% to 100% achievement of the 2025 Revenue Target, and a commission multiplier of 1.5 is applied to the commission rate based on the achievement of the 2025 Revenue Target beyond 100%. Mr. Toquet’s bonus based on the achievement of the 2025 Revenue Target is capped at SEK 2,500,000. Mr. Toquet is also eligible to receive an additional quarterly bonus of $6,000 each if specified quarterly revenue targets based on the 2025 Revenue Target are achieved, to receive an additional strategic account bonus of either $6,000 or $10,000 each time he successfully executes a new intellectual property license agreement meeting an applicable predetermined royalty per chip and deal value, and to receive an additional strategic account bonus of $10,000 if he successfully executes new intellectual property license agreements above a certain predetermined aggregate deal value. The commission-based bonus is payable quarterly based on the criteria discussed above and is subject to any applicable payroll taxes and tax withholdings.
 
Due to their strategic significance, the Corporation believes that the disclosure of the commission rates, quarterly revenue targets, and requisite strategic agreement terms under the Toquet 2025 Plan would cause competitive harm to the Corporation and therefore are not disclosed.
 
The foregoing description of the Toquet 2025 Plan is qualified in its entirety by reference to the complete text of the plan, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 






 
2025 Equity Award to the Corporation’s Executive Officers
 
On February 10, 2025, the Committee granted 12,691, 15,575, 13,844 and 13,844 time-based restricted stock units (“RSU”), effective as of February 14, 2025, to each of Messrs. Panush, Arieli, Boukaya and Toquet, with the number of RSUs to be determined by dividing the grant value by the closing trading price of the Corporation’s common stock on February 14, 2025 (the “Reference Price”). The RSU awards to each of Messrs. Panush, Arieli, Boukaya and Toquet were made pursuant to the Corporation’s 2011 Equity Incentive Plan (the “2011 Plan”) and are contingent on stockholder approval of the amendments to the 2011 Plan, which amendments will be set forth in the proxy statement for the Corporation’s 2025 Annual Meeting of Stockholders (the “Stockholder Approval”). If Stockholder Approval of the amendments to the 2011 Plan is not obtained, the RSU awards will be canceled.  The RSU awards vest 33.4% on February 14, 2026, 33.3% on February 14, 2027 and 33.3% on February 14, 2028.
 
Also, on February 10, 2025, the Committee granted 19,036, 10,383, 9,229 and 9,229 performance-based stock units (“PSUs”), effective as of February 14, 2025, to each of Messrs. Panush, Arieli, Boukaya and Toquet pursuant to the 2011 Plan (collectively, the “Short-Term Executive PSUs”), with the number of PSUs to be determined by dividing the grant value by the Reference Price, and contingent on the Stockholder Approval. If Stockholder Approval of the amendments to the 2011 Plan is not obtained, the PSU awards will be canceled.  The performance goals for the Short-Term Executive PSUs with specified weighting are as follows:
 
Weighting
Goals
50%
Vesting of the full 50% of the PSUs occurs if the Corporation achieves the 2025 license and related revenue target approved by the Board (the “2025 License Revenue Target”). The vesting threshold is achievement of 90% of the 2025 License Revenue Target. If the Corporation’s achievement of the 2025 License Revenue Target, is above 90% but less than 99% of the 2025 License Revenue Target, 91% to 99% of the eligible PSUs would be subject to vesting. If the Corporation’s actual result exceeds 100% of the 2025 License Revenue Target, every 1% increase of the 2025 License Revenue Target, up to 110%, would result in an increase of 7% of the eligible PSUs for Messrs. Arieli, Boukaya and Toquet and an increase of 10% of the eligible PSUs for Mr. Panush.
25%
Vesting of the full 25% of the PSUs occurs if the Corporation achieves positive total shareholder return whereby the return on the Corporation’s stock for 2025 is greater than the S&P Semiconductors Select Industry index (the “S&P index”). The vesting threshold is if the return on the Corporation’s stock for 2025 is at least 90% of the S&P index. If the return on the Corporation’s stock, in comparison to the S&P index, is above 90% but less than 99% of the S&P index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Corporation’s stock exceeds 100% of the S&P index, every 1% increase in comparison to the S&P index, up to 110%, would result in an increase of 7% of the eligible PSUs for Messrs. Arieli, Boukaya and Toquet and an increase of 10% of the eligible PSUs for Mr. Panush.
25%
Vesting of the full 25% of the PSUs occurs if the Corporation achieves positive total shareholder return whereby the return on the Corporation’s stock for 2025 is greater than the Russell 2000 index (the “Russell index”). The vesting threshold is if the return on the Corporation’s stock for 2025 is at least 90% of the Russell index. If the return on the Corporation’s stock, in comparison to the Russell index, is above 90% but less than 99% of the Russell index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Corporation’s stock exceeds 100% of the Russell index, every 1% increase in comparison to the Russell index, up to 110%, would result in an increase of 7% of the eligible PSUs for Messrs. Arieli, Boukaya and Toquet and an increase of 10% of the eligible PSUs for Mr. Panush.
 
Accordingly, assuming maximum achievement of the performance goals set forth above, PSUs representing an additional 100%, meaning an additional 19,036 PSUs would be eligible for vesting of Mr. Panush, and an additional 70%, meaning an additional 7,268, 6,460 and 6,460 PSUs, would be eligible for vesting for each of Messrs. Arieli, Boukaya, and Toquet, respectively.
 
Subject to achievement of the thresholds for the above performance goals for 2025, the Short-Term Executive PSUs vest 33.4% on February 14, 2026, 33.3% on 14, 2027 and 33.3% on February 14, 2028.
 
ITEM 8.01. OTHER EVENTS.
 
Amended Non-Employee Director Compensation Policy
 
On February 11, 2025, the Board, upon recommendation from the Committee following its annual assessment of the Board’s compensation program, approved the following changes to the cash and equity compensation of non-employee directors (as amended, the “Amended and Restated Director Compensation Policy”), which changes adjust the Board’s compensation program to more closely align with the non-employee director compensation practices of the Corporation’s peer group:
 






 
Annual Cash Retainer
 
Effective January 1, 2025, the annual cash retainer fee for service as: (1) a board member will increase from $40,000 to $45,000; (2) the chair of the Board will increase from an additional $22,500 to $57,500, such that the total cash retainer for the chair of the Board will increase from $62,500 to $102,500; (3) members on each of the Audit Committee, Compensation Committee and Nomination and Corporate Governance Committee will increase from $5,000 to $7,500; and (4) the chair of the Compensation Committee will increase from an additional $5,000 to $7,500, such that the total additional cash retainer for the chair of the Compensation Committee will increase from $10,000 to $15,000, as summarized in the table below:
 
   
Non-Chair Member
   
Chair
 
   
Prior
   
New
   
Prior
   
New
 
Board of Directors
  $ 40,000     $ 45,000     $ 62,500     $ 102,500  
Audit Committee
  $ 5,000     $ 7,500     $ 15,000     $ 17,500  
Compensation Committee
  $ 5,000     $ 7,500     $ 10,000     $ 15,000  
Nomination and Corporate Governance Committee
  $ 5,000     $ 7,500     $ 10,000     $ 12,500  
 
Equity Compensation
 
Effective immediately, the annual equity grant of restricted stock units to continuing non-employee directors will increase from an annualized value of $124,670 to $165,000. The annual equity grant, which has historically been granted on or about July 1 of each year, will be made following a director’s election or re-election to the Board at the Corporation’s annual meeting, and fully vest on the first-year anniversary of the grant date instead of over a two-year period. Any new director on the Board would receive a number of restricted stock units based on the same annualized value with the same vesting schedule.
 
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
 
(d) Exhibits:
 
Exhibit
Number
 
Description
     
10.1†
 
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
† Indicates management compensatory plan or arrangement.
 
 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
CEVA, INC.
   
Date: February 14, 2025
By:
/s/ Yaniv Arieli
 
Name:
Yaniv Arieli
 
Title:
Chief Financial Officer
 
 
EX-10.1 2 ex_777781.htm EXHIBIT 10.1 ex_777781.htm

Exhibit 10.1

 

 

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH PORTIONS ARE MARKED AS INDICATED WITH BRACKETS (“[***]”) BELOW.

 

February 14, 2025

 

 

To: Gweltaz Toquet, CCO, Ceva, Inc. (the “Company”)

From: Amir Panush, CEO

 

 

 

2025 Incentive Bonus Plan (“IB Plan”)

 

This document details the composition for your Incentive Bonus for achieving pre-determined targets for calendar year 2025.

 

Effective date/terms: The IB Plan is effective from January 1, 2025 through December 31, 2025, unless modified in writing by the CEO. This plan supersedes all prior commission plans. The Company reserves the right to make changes to the IB Plan at any time with or without advance notice and for any reason, to the extent permitted by applicable law. The Company has the sole and absolute right and discretion to determine when incentive compensation under this IB Plan has been earned. All payments under this IB Plan are subject to deductions and withholdings required by applicable law. Nothing in this IB Plan changes your at-will employment status with the Company.

 

Plan Eligibility: The IB Plan applies to full-time sales personnel. If you resign, your employment is terminated, or you otherwise cease to be an employee of the Company for any reason, you will be eligible to receive payment under the IB Plan based on any revenue amount that is recognized by the Company on or before your last day of employment with the Company. You cannot earn incentive compensation under this IB Plan after your employment with the Company terminates for any reason.

 

The IB Plan provides incentive compensation for achieving recognized revenue targets within three components:

 

 

(A)

Annual Revenue Target (“ART”)

 

(B)

Quarterly Revenue Target (“QRT”)

 

(C)

Strategic Accounts License Agreements (“SA”)

 

For the purposes of the IB Plan, revenue amounts that are “recognized” means bookings that have been invoiced and recognized as revenue by the Company and paid after the end of an applicable quarter (or interim period ending on your termination of employment, if applicable) within 60 days. For purposes of this IB Plan, “bookings” means the Company has signed a deal with a customer, and such deal is not subject to any refund, chargeback, credit, or recoupment by the customer. In the event of any dispute, the Company’s formal, approved and legitimate booking records shall be dispositive evidence, and the determination of booking otherwise by the Company’s board of directors shall be binding absent manifest error.

 







 

ART Compensation

 

1. Payment for achieving 100% ART (subject to additional payment on multiplier): SEK 2,500,000

 

-

ART for Calendar Year 2025 is: $[***]

 

-

Commission Rate: [***]

 

-

Commission Multiplier: Will be applied to the commission rate per the matrix below:

 

Actual Revenue as Percentage of the ART

Commission Multiplier to be Applied

From 0 to 100%

1.0

From 100% and above

1.5

 

 

 

While ART is based on the Company’s annual targets, the IB Plan payment is calculated on a quarterly basis, with annual targets calculated pro rata for each quarter.

 

QRT Compensation

 

$6,000 payment each quarter based on achievement of the following QRT:

 

 

i.

Q1 [***]

 

ii.

Q2 [***]

 

iii.

Q3 [***]

 

iv.

Q4 [***]

 

Strategic Accounts (SA) Compensation

 

 

1.

$6,000 for each new booking of license agreement with any company approved by the CEO and that meets the following pre-requisites:

 

-

License agreement includes an IP licensing fee of $[***] or above, excluding future or pre-paid royalties; and

 

-

Royalty revenue pricing is set at the lowest bracket of greater than [***] cents per Ceva powered chip/device and for WIoT BU products greater than [***] cents per Ceva powered chip/device.

 







 

 

2.

$10,000 for each booking of IP licensing and/or services agreement that meets the following pre-requisites:

 

-

License fee and related fees of $[***] or above, excluding future royalties or pre-paid royalties; and

 

-

Royalty revenue pricing at the lowest bracket, of greater than [***] cents per Ceva powered chip/device and for WIoT BU products greater [***] cents per Ceva powered chip/device.

 

3.

$10,000 for achieving new aggregated booking of license agreements for [***] over $[***].

 

Note: No double counting or double payment will apply for the above Strategic Accounts Compensation section.

 

Any booking must be approved by the Company in questionable deals, i.e., deals in which payment is not made per the applicable license agreement, changes are made to a deal, deal termination occurs, or other non-standard deal terms apply.

 

 

 

 

 

*         *         *

 

 

 

I have read and understand the 2025 Incentive Bonus Plan. I have received a copy of the plan for my record. I accept the terms and conditions of the IB Plan as outlined above and agree that my incentive compensation will be determined according to these terms and conditions.

 

 

 

/s/ Gweltaz Toquet 

 

2/14/2025

Gweltaz Toquet, CCO

 

Date
     
/s/ Amir Panush   2/14/2025

Amir Panush, CEO

 

Date

 

 

 

 

CC: Finance
  HR, Employee File